Rheumatoid arthritis is an inflammatory disease that affects the joints in the human body. It is the most common type of autoimmune disease.
With the coronavirus pandemic continuing its deadly run by infecting more than a million people and causing the death of more than 82,000 people across the world, the laboratories of the Council of Scientific and Industrial Research (CSIR) intensified their efforts at combating the pandemic.
Surveillance at the level of the virus, humans, and geographical origins and distributions is a critical step in combating Covid-19.
CSIR has been leading the fight against COVID-19 and contributing extensively to overcome the deadly coronavirus outbreak.
An advanced virus research laboratory on the lines of the National Institute of Virology in Pune.
Celebrating 30 Years of Effective & Affordable Contraception.
Dr. Saman Habib, Chief Scientist and Professor (AcSIR) in Molecular Biology Division, CSIR-Central Drug Research Institute (CSIR-CDRI, Lucknow, well known for her outstanding work in understanding the malaria parasite, has been elected as Fellow of the Indian National Science Academy (INSA), New Delhi.
CSIR-Central Drug Research Institute, Lucknow, celebrated the 79th CSIR Foundation Day on 28 September 2020.
CSIR-CDRI organised the "CDRI Award-2020 Oration and Felicitation Programme" on 29 September 2020 to promote drug discovery and development research in India.
CSIR-CDRI (Central Drug Research Institut), Lucknow, Principal Scientist, Dr Satish Mishra awarded "Dr Tulsi Das Chugh Award-2020" by the National Academy of Medical Sciences (India).
CSIR-CDRI Scientist, Dr SusantaKar, Honoured with "Prof. A.N. Bhaduri Memorial Lecture Award-2020" by the Society of Biological Chemists (India).
Putting into action, the recent GOI’s provision for CSR funding to support research.
"CSIR-CDRI has championed the cause of affordable drugs and has given the world breakthrough molecules like Centchroman and Arteether”: Dr Harsh Vardhan
Dr Ritu Trivedi, Principal Scientist, CSIR-CDRI, Lucknow has been conferred with the NASI-Reliance Industries Platinum Jubilee Award (2020) in Biological Sciences.
Career opportunities in Science
Prof. Tapas Kundu, Director, CSIR-CDRI, said Identification of small molecule as biomarker is very helpful for drug discovery and disease diagnosis research.
Prof. Tapas Kundu mentioned that Umifenovir (Arbidol) was selected from among 16 suggested candidates of CSIR looking into the feasibility of synthesis using locally available chemicals at the peak of the pandemic.
Prof. Bhabatosh emphasised the urgent need for an armamentarium of the modern health care system to pursue this dream.
Dr Reddy has more than 20 Years of research experience in the synthesis of natural products/medicinal chemistry/drug discovery.
This decade-long research at CDRI provides an insight into developing the first-in-class drug that is likely to modulate the host microbiome.
Dr Tapas Kumar Kundu said, “The nucleic acid staining dye segment seems to be dominated by costly imported products of multinational companies and this make-in-India product is cost-effective and it will reduce our dependency on foreign supplies.”
"Trust, Transparency, Timeline & Mutual Respect are the key to success for the development of Covaxin in record time through Public-Private Partnership”: Prof. Balram Bhargava
Dr Ritu Trivedi, Senior Principal Scientist CSIR-CDRI, Lucknow, got selected for the National Women Scientist Award for Excellence in Translational Research (National Tech Excellence Award for Women-2022) by DST.
Dr Goel informed that the product GreenR™ provides an economical alternative to commercially available dyes that are used to stain DNA/RNA, which are currently imported.
During the concluding session of Swachhta Pakhwada and Technology Day, former President of the Cardiological Society of India and famous cardiologist Dr Mansoor Hasan Khan delivered a very informative lecture on Medical Technology and Humanity.
Prof. ChandrimaShaha, President-INSA highlighted the significance of the programme and said that concepts and ideas from basic research are vital to translation into applications.
This training program will provide knowledge about theoretical, practical training on basic and advanced experimental methods in these techniques.
Dr Radha Rangarajan has been actively involved in translational research and product development in the public health arena for the last two decades.
Evidence-based medicine and rationale use of traditional therapies is the need of hour: Dr Sattigeri Viswajanani
Dr G.P. Talwar, Director Research, Talwar Research Foundation, New Delhi, graced the occasion as chief guest and delivered an informative Foundation Day Lecture on "Mission-oriented Research to Develop Products of High Utility".
India is known as the Triple-Negative Breast Cancer (TNBC) capital of the world owing to its high incidence. TNBC is the deadliest amongst all breast cancer subtypes with few therapeutic options. This type of cancer is associated with early metastasis resulting in poor five-year survival rates.
Participants were briefed about the real-time data of Climate Clockand the Student-Scientist Connect programme to understand the know-how of drug development.
Dr Rajesh Kumar Jha's research group from CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, is working on the biology and management of gynaecological endocrine and metabolic disorders such as endometriosis and Polycystic Ovarian Syndrome (PCOS).
Under the CSIR-Integrated Skill Initiative, CSIR-Central Drug Research Institute is offering a course on Skill Development Programme in Advanced Spectroscopic Techniques.
The agreement signifies a pivotal stride towards self-reliance in the realm of lab reagents and API starting materials for life sciences research.
The objective of this workshop was to empower science teachers with innovative techniques that make the process of teaching more comprehensible, engaging and captivating for students.
“The rationale for developing the pure enantiomer is to reduce the overall chemical burden for the user, in this case, women of reproductive age.” Said Dr Radha Rangarajan, Director, CSIR-CDRI.
The initiative aims to raise awareness about various types of IPR, GI, trademarks, copyrights, and other forms of intellectual property protection.
The event was marked by an enlightening discourse on the burgeoning influence of AI in various aspects of daily life, particularly its transformative role in the realm of agriculture.
The event aimed to inspire and motivate young minds to pursue careers in science, specifically focusing on the exciting field of Drug Discovery and Research.
Dr Radha Rangarajan, Director, CSIR-CDRI, said, “We are excited to work with Dr Reddy’s for the development of APIs.
Dr Sanjeev, Pr Scientist, CSIR-CDRI, provided valuable information to the children about maintaining good health while sharing insights about the medicines developed at CDRI.
The event focused on unravelling the multifaceted role of AI in accelerating healthcare innovations.
Dr Radha Rangarajan congratulated and felicitated the inventors who have pioneered new technologies and developed groundbreaking patents, underscoring CSIR-CDRI’s commitment to innovation and advancement in the pharmaceutical domain.
“Establishment of these Centres of Excellence represents a pivotal step in advancing Ayurveda’s role within the modern healthcare landscape, said Shri Brajesh Pathak, Deputy Chief Minister and Health Minister of Uttar Pradesh.
CSIR-CDRI and Zydus to develop best-in-class drug for Chronic Kidney Disease induced Osteoporosis
